The job below is no longer available.
You might also like
in Groton, CT
Director, Outcomes & Evidence, Avelumab - Global Health & Value
•30 days ago
Hours | Full-time, Part-time |
---|---|
Location | groton, Connecticut |
About this job
Org Marketing Statement
All over the world, Pfizer colleagues are working together to positively impact health for everyone, everywhere. Each position at Pfizer touches and contributes to the success of our business and our world. That's why, as one of the global leaders in the biopharmaceutical industry, Pfizer is committed to seeking out inspired new talent who share our core values and mission of making the world a healthier place.
Role Description
This role is responsible for the development of the Outcomes and Evidence strategy, tactics and
deliverables to ensure the successful launch of Avelumab. Avelumab is an asset that is currently
being jointly developed by Pfizer and Merck Serono, and all major activities are coordinated and
aligned between the two companies. While the Director is primarily responsible for the O&E
support for the Pfizer-led indications, they will need to engage frequently with their counterparts
at Merck Serono, and represent Pfizer Oncology O&E on various committees and coordinated
workstreams.
Responsibilities
* Develop Evidence Blue Print and O&E strategy required to optimize access and commercial
success of Avelumab
* Develop the Value Evidence Suite of Tools (Global value dossiers, Global Cost-effectiveness
and Budget Impact Model, etc.) in conjunction with the regions/countries in preparation for
launch (or updates of these deliverables)
* Design and conduct Outcomes and Evidence studies and other projects (including Non-
Interventional Studies, registries, etc.) to support the global market's evidence needs for access
and reimbursement
* Works closely with cross-functional teams (PI&A, WWCD, CDMA, etc.) both within Pfizer
and across the alliance relationship to ensure aligned and coordinated strategies and activities
* Provide input to clinical development team on clinical and Outcomes and Evidence needs to
ensure global reimbursement and access. Specific requirements include: endpoints, populations and comparators in RCTs that are relevant to global payer decision makers
* Gather input from local country/regional Outcomes and Evidence teams on clinical and
Outcomes and Evidence needs to ensure global market access at time of launch
* Design and conduct burden of illness studies, epidemiology studies, and other related real
world studies
* Development and validation of new Patient Reported Outcomes measures as appropriate for the
asset team
* Provide strategic guidance and content guidance in reimbursement (re)negotiations for Pfizer
products (pricing/market access experience ideal)
* Develop relationships and research opportunities with key OBU external stakeholders including health economists, PRO research, policymakers, etc. in support of Avelumab strategies
Qualifications
Minimum Masters Degree (MSc, MPH) in health services research, public health, epidemiology, or health economics with a preferred Doctoral degree (PhD, DrPH, ScD) in health services research, public health, epidemiology, or health economics or a Doctoral degree in a clinical discipline (medicine, pharmacy, nursing)
At least 5 years' experience working in HEOR in a pharmaceutical company, preferably in a global role
Strong methodological skills (study design, data analysis and interpretation) in cancer epidemiology or health services research is required
Demonstrated skills to develop strategy(ies) for the appropriate utilization of NIS' across clinical, medical, Outcomes and Evidence and commercial disciplines to address key scientific and business questions
In depth understanding of Pharmacoeconomics and patient reported outcomes and HrQoL
Strong working knowledge of the technical and methodological aspects of registries and observational study design and implementation. Capable of independently managing complex registry and non-interventional study projects
Knowledge and experience in the oncology therapeutic area is required, and experience in the immuno oncology field is highly desirable
Experience with the evidence requirements of HTA organizations such as NICE, SMC, PBAC is desirable
Excellent interpersonal skills required: ability to understand and respond to multiple internal and external customers
Excellent oral and written English communication skills required
Strong project management abilities (contracting, budgeting, vendor management) essential.
Demonstrated ability to manage multiple projects (multitask) involving complex processes, significant budget, competing deadlines and rapidly shifting priorities
Ability to influence key members of medical and commercial teams constructively and without conflict
Skilled in functioning within a matrix organization where managing through influence is required
EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.
All over the world, Pfizer colleagues are working together to positively impact health for everyone, everywhere. Each position at Pfizer touches and contributes to the success of our business and our world. That's why, as one of the global leaders in the biopharmaceutical industry, Pfizer is committed to seeking out inspired new talent who share our core values and mission of making the world a healthier place.
Role Description
This role is responsible for the development of the Outcomes and Evidence strategy, tactics and
deliverables to ensure the successful launch of Avelumab. Avelumab is an asset that is currently
being jointly developed by Pfizer and Merck Serono, and all major activities are coordinated and
aligned between the two companies. While the Director is primarily responsible for the O&E
support for the Pfizer-led indications, they will need to engage frequently with their counterparts
at Merck Serono, and represent Pfizer Oncology O&E on various committees and coordinated
workstreams.
Responsibilities
* Develop Evidence Blue Print and O&E strategy required to optimize access and commercial
success of Avelumab
* Develop the Value Evidence Suite of Tools (Global value dossiers, Global Cost-effectiveness
and Budget Impact Model, etc.) in conjunction with the regions/countries in preparation for
launch (or updates of these deliverables)
* Design and conduct Outcomes and Evidence studies and other projects (including Non-
Interventional Studies, registries, etc.) to support the global market's evidence needs for access
and reimbursement
* Works closely with cross-functional teams (PI&A, WWCD, CDMA, etc.) both within Pfizer
and across the alliance relationship to ensure aligned and coordinated strategies and activities
* Provide input to clinical development team on clinical and Outcomes and Evidence needs to
ensure global reimbursement and access. Specific requirements include: endpoints, populations and comparators in RCTs that are relevant to global payer decision makers
* Gather input from local country/regional Outcomes and Evidence teams on clinical and
Outcomes and Evidence needs to ensure global market access at time of launch
* Design and conduct burden of illness studies, epidemiology studies, and other related real
world studies
* Development and validation of new Patient Reported Outcomes measures as appropriate for the
asset team
* Provide strategic guidance and content guidance in reimbursement (re)negotiations for Pfizer
products (pricing/market access experience ideal)
* Develop relationships and research opportunities with key OBU external stakeholders including health economists, PRO research, policymakers, etc. in support of Avelumab strategies
Qualifications
Minimum Masters Degree (MSc, MPH) in health services research, public health, epidemiology, or health economics with a preferred Doctoral degree (PhD, DrPH, ScD) in health services research, public health, epidemiology, or health economics or a Doctoral degree in a clinical discipline (medicine, pharmacy, nursing)
At least 5 years' experience working in HEOR in a pharmaceutical company, preferably in a global role
Strong methodological skills (study design, data analysis and interpretation) in cancer epidemiology or health services research is required
Demonstrated skills to develop strategy(ies) for the appropriate utilization of NIS' across clinical, medical, Outcomes and Evidence and commercial disciplines to address key scientific and business questions
In depth understanding of Pharmacoeconomics and patient reported outcomes and HrQoL
Strong working knowledge of the technical and methodological aspects of registries and observational study design and implementation. Capable of independently managing complex registry and non-interventional study projects
Knowledge and experience in the oncology therapeutic area is required, and experience in the immuno oncology field is highly desirable
Experience with the evidence requirements of HTA organizations such as NICE, SMC, PBAC is desirable
Excellent interpersonal skills required: ability to understand and respond to multiple internal and external customers
Excellent oral and written English communication skills required
Strong project management abilities (contracting, budgeting, vendor management) essential.
Demonstrated ability to manage multiple projects (multitask) involving complex processes, significant budget, competing deadlines and rapidly shifting priorities
Ability to influence key members of medical and commercial teams constructively and without conflict
Skilled in functioning within a matrix organization where managing through influence is required
EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.